Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

NCT01585194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Uveal Melanoma
Stage IV Uveal Melanoma AJCC v7

Interventions

BIOLOGICAL: Ipilimumab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]